4A7Q
Structure of human I113T SOD1 mutant complexed with 4-(4-methyl-1,4- diazepan-1-yl)quinazoline in the p21 space group.
4A7Q の概要
エントリーDOI | 10.2210/pdb4a7q/pdb |
関連するPDBエントリー | 1AZV 1BA9 1DSW 1FUN 1HL4 1HL5 1KMG 1L3N 1MFM 1N18 1N19 1OEZ 1OZT 1OZU 1P1V 1PTZ 1PU0 1RK7 1SOS 1SPD 1UXL 1UXM 2AF2 2C9S 2C9U 2C9V 2V0A 2VR6 2VR7 2VR8 2WKO 2WYT 2WYZ 2WZ0 2WZ5 2WZ6 2XJK 2XJL 4A7G 4A7R 4A7S 4A7T 4A7U 4A7V 4SOD |
分子名称 | SUPEROXIDE DISMUTASE [CU-ZN], 4-(4-METHYL-1,4-DIAZEPAN-1-YL)QUINAZOLINE, SULFATE ION, ... (6 entities in total) |
機能のキーワード | oxidoreductase, amyotrophic lateral sclerosis, antioxidant, disease mutation, metal-binding, zn superoxide dismutase |
由来する生物種 | HOMO SAPIENS (HUMAN) |
細胞内の位置 | Cytoplasm: P00441 |
タンパク質・核酸の鎖数 | 2 |
化学式量合計 | 32949.94 |
構造登録者 | Wright, G.S.A.,Kershaw, N.M.,Antonyuk, S.V.,Strange, R.W.,ONeil, P.M.,Hasnain, S.S. (登録日: 2011-11-14, 公開日: 2012-10-24, 最終更新日: 2013-08-28) |
主引用文献 | Kershaw, N.M.,Wright, G.S.,Sharma, R.,Antonyuk, S.V.,Strange, R.W.,Berry, N.G.,O'Neill, P.M.,Hasnain, S.S. X-Ray Crystallography and Computational Docking for the Detection and Development of Protein-Ligand Interactions. Curr.Med.Chem., 20:569-, 2013 Cited by PubMed Abstract: Amyotrophic lateral sclerosis (ALS) is a progressive neurodegenerative disorder characterised by the selective dysfunction and death of the upper and lower motor neurons. Median survival rates are between 3 and 5 years after diagnosis. Mutations in the gene encoding Cu/Zn superoxide dismutase (SOD1) have been linked to a subset of familial forms of ALS (fALS). Herein, we describe a fragment- based drug discovery (FBDD) approach for the investigation of small molecule binding sites in SOD1. X-ray crystallography has been used as the primary screening method and has been shown to directly detect protein-ligand interactions which cannot be unambiguously identified using other biophysical methods. The structural requirements for effective binding at Trp32 are detailed for a series of quinazoline-containing compounds. The investigation of an additional site that binds a range of catecholamines and the use of computational modelling to assist fragment evolution is discussed. This study also highlights the importance of ligand solubility for successful Xray crystallographic campaigns in lead compound design. PubMed: 23278398DOI: 10.2174/0929867311320040008 主引用文献が同じPDBエントリー |
実験手法 | X-RAY DIFFRACTION (1.22 Å) |
構造検証レポート
検証レポート(詳細版)をダウンロード